PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.78%
Revenue growth at 50-75% of QCOM's 10.80%. Martin Whitman would worry about competitiveness or product relevance.
1.19%
Gross profit growth under 50% of QCOM's 14.56%. Michael Burry would be concerned about a severe competitive disadvantage.
8.44%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
8.44%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
3.96%
Net income growth under 50% of QCOM's 21.67%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.56%
EPS growth of 5.56% while QCOM is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
5.56%
Diluted EPS growth of 5.56% while QCOM is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.59%
Share reduction more than 1.5x QCOM's 21.67%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.84%
Diluted share reduction more than 1.5x QCOM's 21.67%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
38.32%
Dividend growth of 38.32% while QCOM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
30.10%
OCF growth under 50% of QCOM's 78.57%. Michael Burry might suspect questionable revenue recognition or rising costs.
26.88%
FCF growth under 50% of QCOM's 73.21%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
129.53%
10Y revenue/share CAGR under 50% of QCOM's 664.51%. Michael Burry would suspect a lasting competitive disadvantage.
77.01%
5Y revenue/share CAGR under 50% of QCOM's 664.51%. Michael Burry would suspect a significant competitive gap or product weakness.
44.21%
3Y revenue/share CAGR under 50% of QCOM's 191.72%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
2867.62%
OCF/share CAGR of 2867.62% while QCOM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
31.90%
3Y OCF/share CAGR under 50% of QCOM's 736.34%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
378.63%
10Y net income/share CAGR of 378.63% while QCOM is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
3684.73%
Net income/share CAGR of 3684.73% while QCOM is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
303.89%
Below 50% of QCOM's 1066.67%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
37.08%
Equity/share CAGR of 37.08% while QCOM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
53.77%
Below 50% of QCOM's 241.81%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
20.80%
Dividend/share CAGR of 20.80% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
10.83%
3Y dividend/share CAGR of 10.83% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
13.60%
Our AR growth while QCOM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
5.04%
Inventory shrinking or stable vs. QCOM's 60.91%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
8.58%
Similar asset growth to QCOM's 8.60%. Walter Schloss finds parallel expansions or investment rates.
7.55%
Positive BV/share change while QCOM is negative. John Neff sees a clear edge over a competitor losing equity.
4.60%
Debt growth far above QCOM's 4.45%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
2.79%
R&D dropping or stable vs. QCOM's 20.34%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-5.72%
We cut SG&A while QCOM invests at 17.98%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.